| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |